Trial reportDiabetes technology & therapeutics2017
Use of a Novel, Remotely Connected Diabetes Management System Is Associated with Increased Treatment Satisfaction, Reduced Diabetes Distress, and Improved Glycemic Control in Individuals with Insulin-Treated Diabetes: First Results from the Personal Diabetes Management Study.
Trial report in Diabetes technology & therapeutics, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 20 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
ACCU-CHEK Connect Personal Diabetes Management Study (PDM)
Feasibility and Acceptability of a Remote Glucose Monitoring Program for Pregnant Marshallese Women with Pregnancies Complicated by Diabetes
Who cites it
20 citing papers in PubMed, 1 synthesis or guideline pooled it, 43 citations in OpenAlex.
- Behavior Change Content, Understandability, and Actionability of Chronic Condition Self-Management Apps Available in France: Systematic Search and Evaluation.JMIR mHealth and uHealth · 2019Pooled it
- Automated insulin dosing guidance to optimise insulin management in patients with type 2 diabetes: a multicentre, randomised controlled trial.Lancet (London, England) · 2019Trial
- Use of Blood Glucose Meters Featuring Color Range Indicators Improves Glycemic Control in Patients With Diabetes in Comparison to Blood Glucose Meters Without Color (ACCENTS Study).Journal of diabetes science and technology · 2018Trial
- Real-World Evidence on Mobile App-Supported Diabetes Management in Insulin-Treated Patients.Journal of diabetes research · 2025Article
- Impact of a digital application on HbA1c levels in people with diabetes: a randomized controlled trial.Frontiers in digital health · 2025Article
- Beyond the EHR: How Digital Health Tools Foster Participatory Health and Self-Care for Patients with Diabetes.American journal of medicine open · 2023Article
- Guideline Development for Medical Device Technology: Issues for Consideration.Journal of diabetes science and technology · 2023Article
- Article
- Adherence and Persistence to Insulin Therapy in People with Diabetes: Impact of Connected Insulin Pen Delivery Ecosystem.Journal of diabetes science and technology · 2022Review
- Using mHealth applications for self-care - An integrative review on perceptions among adults with type 1 diabetes.BMC endocrine disorders · 2022Review
- Telemedicine in cystic fibrosis.Journal of clinical & translational endocrinology · 2021Article
- Analysis of Effectiveness and Psychological Techniques Implemented in mHealth Solutions for Middle-Aged and Elderly Adults with Type 2 Diabetes: A Narrative Review of the Literature.Journal of clinical medicine · 2021Review
- Impact of Participation in a Virtual Diabetes Clinic on Diabetes-Related Distress in Individuals With Type 2 Diabetes.Clinical diabetes : a publication of the American Diabetes Association · 2020Article
- Managing Diabetes in Hard to Reach Populations: A Review of Telehealth Interventions.Current diabetes reports · 2020Review
- Digital Diabetes Care System Observations from a Pilot Evaluation Study in Vietnam.International journal of environmental research and public health · 2020Article
- The Importance of Telemedicine during COVID-19 Pandemic: A Focus on Diabetic Retinopathy.Journal of diabetes research · 2020Review
- Optimizing mHealth Technologies in Real-World Clinical Practices.Clinical diabetes : a publication of the American Diabetes Association · 2019Article
- Mobile-based insulin dose adjustment for type 2 diabetes in community and rural populations: study protocol for a pilot randomized controlled trial.Therapeutic advances in endocrinology and metabolism · 2019Article
- App-Based Insulin Calculators: Current and Future State.Current diabetes reports · 2018Review
- Insulin therapy for type 2 diabetes - are we there yet? The d-Nav® story.Clinical diabetes and endocrinology · 2018Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe ability to automatically transfer data to clinicians and receive timely guidance in therapy adjustments through remote and in-office consults can positively impact patients' perceptions about quality of care, which is positively associated with clinical outcomes. We assessed the impact of using the Accu-Chek Connect diabetes management system on treatment satisfaction, diabetes distress, and glycemic control in adults with type 1 diabetes and insulin-treated type 2 diabetes. SUBJECTS AND
methodsThis 6-month, prospective, multicenter, single-arm study assessed the impact of using the system on treatment satisfaction and glycemic control among 87 adults with insulin-treated diabetes (multiple daily insulin injections and basal only), with 8.8% ± 1.6% glycated hemoglobin (HbA1c) at baseline. The Diabetes Treatment Satisfaction Questionnaire-status (DTSQs) and Diabetes Distress Scale (DDS) were administered at baseline, and the Diabetes Treatment Satisfaction Questionnaire-change (DTSQc) and DDS at 6 months. Changes in HbA1c, average blood glucose (BG), and other metrics were also assessed.
resultsImprovements in DTSQc scores were observed at 6 months with a total mean (standard deviation) score of 14.3 ± 5.1. Significant reductions in total mean DDS scores from baseline to 6 months were also observed, from 2.0 ± 0.8 to 1.7 ± 0.7, P < 0.0001. A significant reduction in regimen-related distress was notable, from "moderate distress" (2.4 ± 1.0) to "not distressed" (1.9 ± 0.9), P < 0.0001). Significant reductions in mean HbA1c (-0.9 ± 1.6, P < 0.0001) and mean BG (-24.8 ± 50.8, P < 0.0001) were observed.
conclusionsUse of the Accu-Chek Connect diabetes management system is associated with increased treatment satisfaction and improved glycemic control among individuals with insulin-treated diabetes. NCT02600845 ( www.clinicaltrials.gov ).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.